Search clinical trials for: CCX168
Total 15 results
-
AmgenCompletedHealthy VolunteersUnited States
-
ChemoCentryxCompletedHidradenitis Suppurativa | Acne InversaUnited States
-
ChemoCentryxCompletedA Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis (ADVOCATE)ANCA-Associated VasculitisUnited States, Australia, Belgium, Canada, France, Italy, Japan, Netherlands, Spain, United Kingdom, Austria, Czechia, Denmark, Germany, Hungary, Ireland, New Zealand, Norway, Sweden, Switzerland
-
AmgenCompletedAnti-neutrophil Cytoplasmic Antibody-associated VasculitisJapan
-
Mario Negri Institute for Pharmacological ResearchChemoCentryxTerminated
-
ChemoCentryxMedpace, Inc.CompletedC3 Glomerulopathy (C3G)United States, Spain, France, Netherlands, Belgium, Canada, Denmark, Germany, Ireland, Italy, United Kingdom
-
AmgenCompletedAnti-neutrophil Cytoplasmic Antibody-associated VasculitisUnited States
-
ChemoCentryxCompletedImmunoglobulin A NephropathyUnited States, Sweden
-
AmgenRecruitingAntineutrophil Cytoplasmic Antibody-associated VasculitisUnited States
-
ChemoCentryxCompletedVasculitisFrance, United Kingdom, Germany, Belgium, Poland, Netherlands, Hungary, Austria, Sweden, Czechia
-
AmgenCompletedHepatic ImpairmentUnited States
-
AmgenCompletedAnti-neutrophil Cytoplasmic Antibody-associated VasculitisUnited States
-
AmgenCompletedA Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CCX168 in Healthy ParticipantsVasculitis | Systemic Lupus Erythematosus (SLE)Switzerland
-
AmgenCompletedAnti-neutrophil Cytoplasmic Antibody-associated VasculitisUnited States
-
ChemoCentryxCompletedANCA-associated VasculitisUnited States, Canada